Trial intelligence / Profile preview

Androgen Modulation of Response to Selective Phosphodiesterase Inhibitors in Erectile Dysfunction

NCT00512707Phase 4Completed

Sponsor
Boston University
Start
Nov 2006
Primary completion
May 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of Testosterone TEPI patch in erectile dysfunction (ED), testosterone deficiency (TD), sponsored by Boston University. Started Nov 2006; status: completed.

02

Drugs

Testosterone TEPI patch
03

Conditions

erectile dysfunction (ED)testosterone deficiency (TD)

Beyond the preview

Go deeper on NCT00512707.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00512707.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call